Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Non-Current Deferred Tax Liability (2023 - 2024)

Historic Non-Current Deferred Tax Liability for Onconetix (ONCO) over the last 2 years, with Q3 2024 value amounting to $2.9 million.

  • Onconetix's Non-Current Deferred Tax Liability changed N/A to $2.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $2.9 million, marking a year-over-year change of. This contributed to the annual value of $3.1 million for FY2023, which is N/A changed from last year.
  • As of Q3 2024, Onconetix's Non-Current Deferred Tax Liability stood at $2.9 million.
  • In the past 5 years, Onconetix's Non-Current Deferred Tax Liability ranged from a high of $3.1 million in Q4 2023 and a low of $2.7 million during Q1 2024